CLOSTRIDIUM DIFFICILE ANTIBODIES

Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin A. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminat...

Full description

Saved in:
Bibliographic Details
Main Authors JOHNSTONE, DARRELL, BERRY, JODY, CASSAN, ROBYN, TOTH, DEREK
Format Patent
LanguageEnglish
French
Published 28.02.2013
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

Abstract Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin A. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection. L'invention concerne des compositions et des méthodes de traitement ou de prévention de l'infection Clostridium difficile chez un sujet. Les compositions comprennent des anticorps à la toxine Clostridium difficile A. Les méthodes permettent l'administration de ces anticorps à un sujet en quantité efficace pour réduire, éliminer ou prévenir une rechute de l'infection bactérienne par Clostridium difficile.
AbstractList Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin A. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection. L'invention concerne des compositions et des méthodes de traitement ou de prévention de l'infection Clostridium difficile chez un sujet. Les compositions comprennent des anticorps à la toxine Clostridium difficile A. Les méthodes permettent l'administration de ces anticorps à un sujet en quantité efficace pour réduire, éliminer ou prévenir une rechute de l'infection bactérienne par Clostridium difficile.
Author JOHNSTONE, DARRELL
CASSAN, ROBYN
BERRY, JODY
TOTH, DEREK
Author_xml – fullname: JOHNSTONE, DARRELL
– fullname: BERRY, JODY
– fullname: CASSAN, ROBYN
– fullname: TOTH, DEREK
BookMark eNrjYmDJy89L5WRQcPbxDw4J8nTxDPVVcPF0c_N09vRxVXD0C_F08nfxdA3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBobGBkYWFoYGjobGxKkCAGfsJJc
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ANTICORPS DU CLOSTRIDIUM DIFFICILE
ExternalDocumentID WO2013028810A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2013028810A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:59:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2013028810A13
Notes Application Number: WO2012US51948
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130228&DB=EPODOC&CC=WO&NR=2013028810A1
ParticipantIDs epo_espacenet_WO2013028810A1
PublicationCentury 2000
PublicationDate 20130228
PublicationDateYYYYMMDD 2013-02-28
PublicationDate_xml – month: 02
  year: 2013
  text: 20130228
  day: 28
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies JOHNSTONE, DARRELL
CASSAN, ROBYN
BERRY, JODY
CANGENE CORPORATION
TOTH, DEREK
RelatedCompanies_xml – name: JOHNSTONE, DARRELL
– name: CASSAN, ROBYN
– name: CANGENE CORPORATION
– name: BERRY, JODY
– name: TOTH, DEREK
Score 2.8721764
Snippet Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title CLOSTRIDIUM DIFFICILE ANTIBODIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130228&DB=EPODOC&locale=&CC=WO&NR=2013028810A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAaYJM9ChILrAxJKma5JoYqprYZlmpGuZaJxilGRqZmkMPqfA18_MI9TEK8I0gokhB7YXBnxOaDn4cERgjkoG5vcScHldgBjEcgGvrSzWT8oECuXbu4XYuqhBe8egWTgjCzUXJ1vXAH8Xf2c1Z2dgv03NLwgqZ2FhaOAI7CuxghrSoJP2XcOcQPtSCpArFTdBBrYAoHl5JUIMTKl5wgyczrC714QZOHyhU95AJjT3FYswKDj7-AeHBHm6eIb6Krh4url5Onv6uCo4-oV4OvmD2nWiDMpuriHOHrpAq-LhPosP90d2l7EYAwuwz58qwaCQaAEMxCTLNJMU8xSTJNOkxGRDI2DlnZZmkZpkYJxiJskgg88kKfzS0gxcRuBbHUA7s2UYWEqKSlNlgXVrSZIcOEgAJ4132A
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWlb8WtX2sfhqxpS6P9GLPTvZVmbUGQOVzFf99L6HRPewsJXD64y-WX5H4HcI86YXJSEAWVpVL0XDcUy65Uxc61QmWGaWuCpyCKzWCmP82NeQs-NrEwgif0R5AjokUt0N5rsV-v_i-xXPG3cv3A3rHq89FPR67coGP-CqdasuuMvEniJkQmBHGbHE-bNssa9MeIlfaGnJ-XH55eHR6Xstp2Kv4R7E9Q3rI-hla57EKHbHKvdeEgap68sdhY3_oEJBImL-mUunQWSS71fUpo6EnjOKVOws91p3DneykJFOwq-5tZ9pZsj0s7gzZi_vIcpNzCRWR2pRfDQmcGyxcDFZ13VVkl62uFeQG9XZIudzffQidIozALafx8BYeqyPDAo7R70K6_vstr9LM1uxHL8wvqLnrF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CLOSTRIDIUM+DIFFICILE+ANTIBODIES&rft.inventor=JOHNSTONE%2C+DARRELL&rft.inventor=BERRY%2C+JODY&rft.inventor=CASSAN%2C+ROBYN&rft.inventor=TOTH%2C+DEREK&rft.date=2013-02-28&rft.externalDBID=A1&rft.externalDocID=WO2013028810A1